CMS-2026-2179-0002

Status: Original and derived artifacts are available for this document.

Download: pdf

8/10/26, 7:36 AM

CMS-2026-2179-0002.html

PUBLIC SUBMISSION

As of: 8/10/26, 7:36 AM
Received: August 04, 2026
Status: Posted
Posted: August 10, 2026
Tracking No. mse-8r9a-pndc
Comments Due: August 10, 2026
Submission Type: Web

Docket: CMS-2026-2179
Medicare Coverage of Items and Services for Coverage with Evidence Development (CMS-10697)
Comment On: CMS-2026-2179-0001
Medicare Coverage of Items and Services for Coverage with Evidence Development (CMS-10697)
Document: CMS-2026-2179-0002
Comment on CMS-2026-2179-0001

Submitter Information
Name: Anonymous Anonymous

General Comment
I appreciate the opportunity to comment on the Centers for Medicare & Medicaid Services (CMS) policy
on Medicare Coverage of Items and Services for Coverage with Evidence Development (CED). I support
CMS’s continued use of Coverage with Evidence Development as it provides a balance between
expanding access to innovative healthcare services and making sure that Medicare beneficiaries receive
treatments supported by scientific evidence. As medical technology advances over the coming years, new
treatments, procedures, and healthcare services are developed at a quick pace. Many of these innovations
have the potential to improve patient outcomes, yet it is significantly important that Medicare coverage
decisions are based on evidence displaying safety. The CED process will ensure that patients can access
treatments as well as collect additional information to better understand their long-term benefits and risks.

file:///C:/Users/KU52/Downloads/CMS-2026-2179-0002.html

1/1